Categories: HealthcareNews

PointClickCare Appoints David Pessis as Chief Product and Technology Officer to Drive AI-Powered Innovation and Growth

Seasoned technology leader to oversee unified product and engineering teams with an AI-first vision, positioning PointClickCare for its next wave of healthcare transformation

TORONTO, Sept. 16, 2025 /PRNewswire/ — PointClickCare, a leading health tech company helping providers deliver exceptional care, today announced the appointment of David Pessis as its new chief product and technology officer (CPTO). With deep expertise in Artificial Intelligence (AI) and transformative technology leadership, David is poised to drive the company’s next phase of innovation and growth.

David brings over two decades of experience leading cutting-edge technology initiatives at the intersection of AI, product strategy, and enterprise solutions. With a strong background in developing and implementing AI-driven solutions to address complex business challenges, David’s leadership will empower team members to further expand PointClickCare’s AI-enabled platform offerings that enhance clinical decision support, optimize operational efficiency, and improve patient outcomes.

“David’s appointment comes at a pivotal moment for PointClickCare as we advance our commitment to industry-leading healthcare technology and accelerate our growth into the future,” says Dave Wessinger, chief executive officer, PointClickCare. “His strategic vision and experience will be crucial as we harness AI to drive meaningful impact for our customers and the healthcare industry at large.”

David will oversee all aspects of product development and technology strategy, working to advance PointClickCare’s vision of transforming healthcare through innovative, cloud-based solutions. By integrating advanced AI capabilities, he will help drive the organization’s commitment to delivering smarter, more personalized tools that empower care teams to make faster, data-driven decisions, and improve quality of care.

“I am honored to join PointClickCare at such an important time,” said David. “The company’s dedication to transforming healthcare through technology aligns perfectly with my passion for applying AI in meaningful ways. Together, we will drive innovation that not only fuels business growth but also makes a real difference in people’s lives.”

PointClickCare’s appointment of David to the CPTO role underscores the company’s unwavering commitment to shaping the future of healthcare through bold investments in technology and talent. Succeeding Bill McQuaide — whose nearly twelve years of dedicated leadership as chief product officer and, more recently, chief technology officer has had a profound impact — David steps into this role ready to propel the organization into its next era of digital transformation.

To learn more about how PointClickCare is advancing healthcare, visit www.pointclickcare.com.

About PointClickCare

PointClickCare is a leading health tech company with one simple mission: to help providers deliver exceptional care. With the largest long–term and post–acute care dataset, we power AI-driven healthcare to deliver intelligent transitions, insightful interventions, and improved financial performance. Enhanced by our marketplace of 400+ integrated partners and trusted by over 30,000 provider organizations and every major U.S. health plan, we’re redefining healthcare, so it doesn’t just survive — it thrives.

Media Contact
PointClickCare
media@pointclickcare.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/pointclickcare-appoints-david-pessis-as-chief-product-and-technology-officer-to-drive-ai-powered-innovation-and-growth-302556802.html

SOURCE PointClickCare

Staff

Recent Posts

Restart Life Sciences Announces Closing First Tranche of Financing

Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

56 minutes ago

TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg

Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

56 minutes ago

Correction to MyndTec Inc. Press Release Issued December 3, 2025 Regarding Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 5, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), announced…

56 minutes ago

Atropos Health Expands Oncology Precision Medicine Capabilities with Publication of New AI Algorithms for Rare Disease and Integration of ASCO Guidelines

Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform…

6 hours ago

USF and Old Dominion to Play in the 2025 StaffDNA Cure Bowl

PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were…

6 hours ago

The Dot Corp Expands Services With New Promotional Products & Apparel Division

IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp has expanded its services with…

6 hours ago